VEGFA and age-related macular degeneration: In this specific context, a Mg-based drug delivery device for the treatment of age-related macular degeneration (AMD), currently treated with monthly injections of anti-vascular endothelial growth factors (anti-VEGF) drugs in the posterior chamber of the eye [8], might be a solution to be proposed.